insights_auto
Why is INO down 2.05%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.43
arrow_downward
-2.05%(-0.030) 1D
$1.41
arrow_downward
-1.08% (-0.015)todayPre-market
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.44
High
$1.48
Low
$1.39
Mkt. cap
267.85M
Avg. vol.
19.26M
Volume
30.92K
52-wk high
$2.72
52-wk low
$0.56
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Open
$1.44
High
$1.48
Low
$1.39
Mkt. cap
267.85M
Avg. vol.
19.26M
Volume
30.92K
52-wk high
$2.72
52-wk low
$0.56
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
19 minutes ago
Barclays joins Morgan Stanley in seeing S&P 500 at 8,700 by end-2027
Yahoo Finance
·
1 hour ago
A Tesla Merger Could Fast-Track SpaceX Into the S&P 500. Index Funds Would Have to Buy
Serrari Group
·
4 hours ago
Goldman Sachs Sees S&P 500 at 8,700 as AI Boom Slows
TradingKey
·
3 hours ago
Nasdaq Returns to Correction Territory, Poised to Challenge 27,000 Again by End of 2026
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com